XPO1 |
XPO1, CRM1: Exportin-1 |
CENTB1 |
CENTB1, KIAA0050: Centaurin-beta 1 |
4.225 |
Evidence |
|
KIAA0117 |
RBM34, KIAA0117: RNA-binding protein 34 |
EIF3S2 |
EIF3S2, TRIP1: Eukaryotic translation initiation factor 3 subunit 2 |
4.225 |
Evidence |
|
JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
PSMA6 |
PSMA6, PROS27: Proteasome subunit alpha type-6 |
4.225 |
Evidence |
|
USP14 |
USP14, TGT: Ubiquitin carboxyl-terminal hydrolase 14 |
RAD23A |
RAD23A: UV excision repair protein RAD23 homolog A |
4.225 |
Evidence |
|
PRKCA |
PRKCA, PKCA, PRKACA: Protein kinase C alpha type |
RHOB |
RHOB, ARH6, ARHB: Rho-related GTP-binding protein RhoB precursor |
4.215 |
Evidence |
|
SF3A1 |
SF3A1, SAP114: Splicing factor 3 subunit 1 |
CREBBP |
CREBBP, CBP: CREB-binding protein |
4.212 |
Evidence |
|
SERPINE1 |
SERPINE1, PAI1, PLANH1: Plasminogen activator inhibitor 1 precursor |
SERPINF2 |
SERPINF2, AAP, PLI: Alpha-2-antiplasmin precursor |
4.21 |
Evidence |
|
IL2RA |
IL2RA: Interleukin-2 receptor alpha chain precursor |
EFNB2 |
EFNB2, EPLG5, HTKL, LERK5: Ephrin-B2 precursor |
4.21 |
Evidence |
|
PLCG1 |
PLCG1, PLC1: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 |
DSTN |
DSTN, ACTDP, DSN: Destrin |
4.21 |
Evidence |
|
HRG |
HRG: Histidine-rich glycoprotein precursor |
SERPINE1 |
SERPINE1, PAI1, PLANH1: Plasminogen activator inhibitor 1 precursor |
4.21 |
Evidence |
|
MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
YWHAH |
YWHAH, YWHA1: 14-3-3 protein eta |
4.21 |
Evidence |
|
IL5 |
IL5: Interleukin-5 precursor |
EFNB2 |
EFNB2, EPLG5, HTKL, LERK5: Ephrin-B2 precursor |
4.21 |
Evidence |
|
MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
GPA33 |
GPA33: Cell surface A33 antigen precursor |
4.21 |
Evidence |
|
WASPIP |
IPI00552369 |
S100B |
S100B: Protein S100-B |
4.21 |
Evidence |
|
SERPINE1 |
SERPINE1, PAI1, PLANH1: Plasminogen activator inhibitor 1 precursor |
SERPING1 |
SERPING1, C1IN, C1NH: Plasma protease C1 inhibitor precursor |
4.21 |
Evidence |
|
DSTN |
DSTN, ACTDP, DSN: Destrin |
TMSL8 |
TMSL8, TMSNB: NB thymosin beta |
4.21 |
Evidence |
|
KNG1 |
IPI00215894 |
SERPINE1 |
SERPINE1, PAI1, PLANH1: Plasminogen activator inhibitor 1 precursor |
4.21 |
Evidence |
|
TMSB4X |
TMSB4X, TB4X, THYB4, TMSB4: Thymosin beta-4 |
CAP1 |
CAP1, CAP: Adenylyl cyclase-associated protein 1 |
4.21 |
Evidence |
|
GHR |
GHR: Growth hormone receptor precursor |
ITIH4 |
ITIH4, IHRP, PRO1851, ITIHL1, PK120: Inter-alpha-trypsin inhibitor heavy chain H |
4.205 |
Evidence |
|
GNA15 |
GNA15, GNA16: Guanine nucleotide-binding protein alpha-15 subunit |
SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
4.205 |
Evidence |
|
NR3C1 |
NR3C1, GRL: Glucocorticoid receptor |
KPNA2 |
KPNA2, RCH1, SRP1: Importin subunit alpha-2 |
4.205 |
Evidence |
|
RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
4.197 |
Evidence |
|
RGS7 |
RGS7: Regulator of G-protein signaling 7 |
OPRM1 |
OPRM1, MOR1: Mu-type opioid receptor |
4.197 |
Evidence |
|
PDPK1 |
PDPK1, PDK1: 3-phosphoinositide-dependent protein kinase 1 |
TH |
TH, TYH: Tyrosine 3-monooxygenase |
4.197 |
Evidence |
|
TAOK1 |
TAOK1, KIAA1361, MAP3K16: Serine/threonine-protein kinase TAO1 |
EPB41L1 |
EPB41L1, KIAA0338: Band 4.1-like protein 1 |
4.197 |
Evidence |
|